Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 2.449
1.
Psychopharmacology (Berl) ; 241(6): 1111-1124, 2024 Jun.
Article En | MEDLINE | ID: mdl-38702473

RATIONALE: Evidence on the effect of dopamine D1-like and D2-like receptor antagonists on licking microstructure and the forced swimming response led us to suggest that (i) dopamine on D1-like receptors plays a role in activating reward-directed responses and (ii) the level of response activation is reboosted based on a process of evaluation of response efficacy requiring dopamine on D2-like receptors. A main piece of evidence in support of this hypothesis is the observation that the dopamine D2-like receptor antagonist raclopride induces a within-session decrement of burst number occurring after the contact with the reward. The few published studies with a detailed analysis of the time-course of this measure were conducted in our laboratory. OBJECTIVES: The aim of this review is to recapitulate and discuss the evidence in support of the analysis of the within-session burst number as a behavioural substrate for the study of the mechanisms governing ingestion, behavioural activation and the related evaluation processes, and its relevance in the analysis of drug effects on ingestion. CONCLUSIONS: The evidence gathered so far suggests that the analysis of the within-session time-course of burst number provides an important behavioural substrate for the study of the mechanisms governing ingestion, behavioural activation and the related evaluation processes, and might provide decisive evidence in the analysis of the effects of drugs on ingestion. However, further evidence from independent sources is necessary to validate the use and the proposed interpretation of this measure.


Dopamine , Receptors, Dopamine D1 , Receptors, Dopamine D2 , Dopamine/metabolism , Animals , Humans , Receptors, Dopamine D1/metabolism , Receptors, Dopamine D1/antagonists & inhibitors , Receptors, Dopamine D2/metabolism , Receptors, Dopamine D2/drug effects , Time Factors , Dopamine Antagonists/pharmacology , Reward , Eating/drug effects , Eating/physiology , Drinking Behavior/drug effects , Drinking Behavior/physiology , Dopamine D2 Receptor Antagonists/pharmacology , Dopamine D2 Receptor Antagonists/administration & dosage
2.
Psychopharmacology (Berl) ; 241(6): 1277-1286, 2024 Jun.
Article En | MEDLINE | ID: mdl-38413456

RATIONALE: Schedule-induced drinking (SID) reproduces an excessive and repetitive behavioural pattern that has led to propose this procedure as an animal model to study compulsive behaviours. Although it is known that cannabis can cause several adverse effects, in recent years there has been great interest in the medical application of cannabis derivatives for obsessive-compulsive related disorders. OBJECTIVES: The present study investigated the effects of repeated THC administration on rates of previously acquired SID, as well as the possible alteration of its temporal distribution along inter-food intervals. METHODS: Male Wistar rats acquired SID under a 30 min fixed-time 30-sec food delivery schedule (from 30 to 43 sessions to reach a stable level). Thereafter, 5 or 10 mg/kg daily i.p. injections of THC or vehicle were repeatedly administered for 7 days to evaluate the effects on SID. RESULTS: Repeated THC administration at a dose of 5 mg/kg resulted in an increase on licking. Surprisingly, no effects on SID were observed with the 10 mg/kg dose. However, magazine entries were reduced with both THC doses. THC also modified the temporal distributions of licking and magazine entries during inter-food intervals. CONCLUSIONS: The present results show that repeated THC administration may (i) increase induced licking at moderate doses, (ii) reduce magazine entries, and (iii) affect the temporal pattern of SID. These findings suggest that THC does not appear to be beneficial to reduce compulsive behaviour in this animal model, while another collateral effect of THC -such as a greater habitual-like behaviour- needs to be considered.


Dose-Response Relationship, Drug , Dronabinol , Rats, Wistar , Animals , Male , Dronabinol/administration & dosage , Dronabinol/pharmacology , Rats , Reinforcement Schedule , Compulsive Behavior/chemically induced , Disease Models, Animal , Drinking Behavior/drug effects , Behavior, Animal/drug effects , Drug Administration Schedule
3.
Bull Exp Biol Med ; 171(5): 572-575, 2021 Sep.
Article En | MEDLINE | ID: mdl-34617175

The role of stable hydrogen isotopes in the thermoregulation and its regulation is poorly studied. We analyzed fluctuations in body temperature and changes in thermoregulation parameters in mice under conditions of reduced deuterium intake. The study was performed on male C57BL/6 mice that consumed water with a low (10 ppm) and normal (146 ppm) deuterium content. In 7 days, fluctuations of body temperature, locomotor activity, and oxygen uptake were assessed. Deuterium depletion in the body reduced the mean value of minute fluctuations of body temperature and the mean spectral density of minute fluctuations in body temperature in the 2-20-min periods. This attested to a stabilizing effect of deuterium depletion on the rhythms of body temperature fluctuations, without significant shifts in the thermogenesis parameters. Thus, drinking water with reduced deuterium content makes them less sensitive to external influences.


Body Temperature Regulation , Deuterium/pharmacokinetics , Drinking Behavior/physiology , Animals , Body Temperature/drug effects , Body Temperature/physiology , Body Temperature Regulation/drug effects , Body Temperature Regulation/physiology , Deuterium/analysis , Deuterium/pharmacology , Drinking Behavior/drug effects , Locomotion/drug effects , Locomotion/physiology , Male , Mice , Mice, Inbred C57BL , Thermogenesis/drug effects , Thermogenesis/physiology , Water/chemistry , Water/metabolism , Water/pharmacology
4.
Biomed Res Int ; 2021: 6524658, 2021.
Article En | MEDLINE | ID: mdl-34712734

Plukenetia volubilis Linneo (P. volubilis), or Sacha inca, is an oleaginous plant from the Euphorbiaceae family. The presence of terpenoids, saponins, tannins, glycosides, phytosterols, and phenolic compounds in the ethanol extracts of P. volubilis L leaves has been reported, showing a range of bioactivities including antimicrobial, anti-inflammatory, antioxidant, and analgesia. However, the safety of this plant has not yet been reported explicitly. This study thus is aimed at evaluating the toxicity of the ethanol extract of P. volubilis leaves (EtPV) by acute and subchronic toxicity tests in Swiss albino mice following standard procedures set by The Organization for Economic Cooperation and Development (OECD) with slight modifications. In the acute toxicity test, the treatment groups were administered orally with the EtPV at doses of 1000, 3000, 5000, and 7000 mg/kg body weight in small fractions during 16 hours, and the mice were then observed in 14 consecutive days. In the subchronic toxicity study, the EtPV was given at doses of 100, 300, 500, and 700 mg/kg body weight for 90 days. Changes in behavior, mortality rate, and body and the weights of vital organs, hematology, clinical biochemistry, urine analysis, and histologic morphology were evaluated. The acute toxicity study showed that the EtPV causes no sign of toxicity or mortality. The hematological, biochemical and urine analyses, changes in the weight of the body and vital organs (heart, liver and kidney), and histopathological analyses of organs indicated no evidence of toxicity at any doses. It was also revealed that oral administration of EtPV is safe at the oral doses set by acute and subchronic toxicity tests, and the oral lethal dose for the EtPV is higher than 7000 mg/kg. This study is the first to confirm the safety of P. volubilis leaf ethanol extract, and as a result, encouraging further investigation to examine EtPV potential for traditional medicine.


Complex Mixtures/toxicity , Ethanol/chemistry , Euphorbiaceae/chemistry , Plant Extracts/toxicity , Plant Leaves/chemistry , Toxicity Tests, Acute , Toxicity Tests, Subchronic , Animals , Behavior, Animal/drug effects , Body Weight/drug effects , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Male , Mice , Organ Size/drug effects , Phytochemicals/analysis , Urinalysis
5.
Mol Neurobiol ; 58(11): 5667-5681, 2021 Nov.
Article En | MEDLINE | ID: mdl-34387814

The activity of the midbrain dopamine system reflects the valence of environmental events and modulates various brain structures to modify an organism's behavior. A series of recent studies reported that the direct and indirect pathways in the striatum are critical for instrumental learning, but the dynamic changes in dopamine neuron activity that occur during negative reinforcement learning are still largely unclear. In the present study, by using a negative reinforcement learning paradigm employing foot shocks as aversive stimuli, bidirectional changes in substantia nigra pars compacta (SNc) dopamine neuron activity in the learning and habituation phases were observed. The results showed that in the learning phase, before mice had mastered the skill of escaping foot shocks, the presence of foot shocks induced a transient reduction in the activity of SNc dopamine neurons; however, in the habituation phase, in which the learned skill was automated, it induced a transient increase. Microinjection of a dopamine D1 receptor (D1R) or D2 receptor (D2R) antagonist into the dorsomedial striatum (DMS) significantly impaired learning behavior, suggesting that the modulatory effects of dopamine on both the direct and indirect pathways are required. Moreover, during the learning phase, excitatory synaptic transmission to DMS D2R-expressing medium spiny neurons (D2-MSNs) was potentiated. However, upon completion of the learning and habituation phases, the synapses onto D1R-expressing medium spiny neurons (D1-MSNs) were potentiated, and those onto D2-MSNs were restored to normal levels. The bidirectional changes in both SNc dopamine neuron activity and DMS synaptic plasticity might be the critical neural correlates for negative reinforcement learning.


Dopamine/physiology , Dopaminergic Neurons/physiology , Mesencephalon/physiology , Reinforcement, Psychology , Animals , Benzazepines/pharmacology , Corpus Striatum/physiology , Dopamine D2 Receptor Antagonists/pharmacology , Dopamine Plasma Membrane Transport Proteins/genetics , Dopamine Plasma Membrane Transport Proteins/metabolism , Dopaminergic Neurons/metabolism , Drinking Behavior/drug effects , Electroshock , Genetic Vectors/administration & dosage , Genetic Vectors/pharmacology , Glutamic Acid/metabolism , Habituation, Psychophysiologic/drug effects , Habituation, Psychophysiologic/physiology , Male , Mice , Mice, Inbred C57BL , Receptors, Dopamine D1/antagonists & inhibitors , Receptors, Dopamine D1/physiology , Receptors, Dopamine D2/physiology , Recombinant Proteins/metabolism , Single-Cell Analysis , Sucrose , Synaptic Transmission
6.
Molecules ; 26(16)2021 Aug 04.
Article En | MEDLINE | ID: mdl-34443306

This study aimed to evaluate and compare the effects of co-treatment with purified annatto oil (PAO) or its granules (GRA, Chronic®) with that of testosterone on the orchiectomy-induced osteoporosis in Wistar rats. After surgery, rats were treated from day 7 until day 45 with testosterone only (TES, 7 mg/kg, IM) or TES + PAO or GRA (200 mg/kg, p.o.). The following parameters were evaluated: food/water intake, weight, HDL, LDL, glucose, triglycerides (TG), total cholesterol (TC), alkaline phosphatase levels, blood phosphorus and calcium contents, femur weight, structure (through scanning electron microscopy), and calcium content (through atomic absorption spectrophotometry). Our results show that orchiectomy could significantly change the blood lipid profile and decrease bone integrity parameters. Testosterone reposition alone could improve some endpoints, including LDL, TC, bone weight, and bone calcium concentration. However, other parameters were not significantly improved. Co-treatment with PAO or GRA improved the blood lipid profile and bone integrity more significantly and improved some endpoints not affected by testosterone reposition alone (such as TG levels and trabeculae sizes). The results suggest that co-treatment with annatto products improved the blood lipid profile and the anti-osteoporosis effects of testosterone. Overall, GRA had better results than PAO.


Bixaceae/chemistry , Carotenoids/chemistry , Femur/drug effects , Lipids/blood , Orchiectomy , Osteoporosis/blood , Osteoporosis/etiology , Plant Extracts/chemistry , Plant Oils/pharmacology , Testosterone/pharmacology , Animals , Body Weight/drug effects , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Femur/ultrastructure , Male , Protective Agents/pharmacology , Rats, Wistar
7.
Food Chem Toxicol ; 151: 112108, 2021 May.
Article En | MEDLINE | ID: mdl-33741479

Cylindrospermopsin (CYN) is a toxin with a world-wide increasing occurrence. It can induce toxic effects both in humans and the environment, and toxicity studies are needed to complete its toxicological profile. In this sense, in vivo oral toxicity studies with pure CYN are scarce. The aim of this work was to perform a repeated dose 28-day oral study in rats following the OECD guideline 407 to provide information on health hazard likely to arise from this kind of exposure. Male and female Sprague-Dawley rats were dosed with 18.75, 37.5 and 75 µg CYN/kg b.w./day. After the study period, no clinical signs or mortality and no significant differences in final body weight, body weight gain and total feed intake in both sexes were observed. Only in females some biochemical parameters (triglycerides (TRIG) levels and aspartate aminotransferase (AST) activity) as well as changes in the weight of organs (absolute liver weight values, relative kidney/body weight ratios or relative liver weight/brain weight ratios) were altered, but without toxicological relevance. Histopathological analysis revealed a very mild affectation of liver and kidney in rats. These results suggest the need to perform longer oral toxicity studies to define the potential consequences of long term CYN exposure.


Alkaloids/toxicity , Administration, Oral , Alkaloids/administration & dosage , Animals , Body Weight/drug effects , Clinical Chemistry Tests , Cyanobacteria Toxins , Dose-Response Relationship, Drug , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Female , Hematologic Tests , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Male , Organ Size/drug effects , Rats , Rats, Sprague-Dawley
8.
Am J Physiol Regul Integr Comp Physiol ; 320(3): R236-R249, 2021 03 01.
Article En | MEDLINE | ID: mdl-33206556

Recent work identified Gpr160 as a candidate receptor for cocaine- and amphetamine-regulated transcript peptide (CARTp) and described its role in pain modulation. The aims of the present study were to determine if Gpr160 is required for the CARTp's ability to reduce food intake and water intake and to initially identify the distribution of Gpr160-like immunoreactivity (Gpr160ir) in the rat brain. A passive immunoneutralization approach targeting Gpr160 was used to block the behavioral effects of a pharmacological dose of CARTp in the fourth cerebroventricle (4V) of rats and to determine the importance of endogenously produced CARTp in the control of ingestive behaviors. Passive immunoneutralization of Gpr160 in the 4V blocked the actions of CARTp to inhibit food intake and water intake. Blockade of Gpr160 in the 4V, independent of pharmacological CART treatment, caused an increase in both overnight food intake and water intake. The decrease in food intake, but not water intake, caused by central injection of CARTp was demonstrated to be interrupted by prior administration of a glucagon-like peptide 1 (GLP-1) receptor antagonist. Gpr160ir was observed in several, distinct sites throughout the rat brain, where CARTp staining has been described. Importantly, Gpr160ir was observed to be present in both neuronal and nonneuronal cell types. These data support the hypothesis that Gpr160 is required for the anorexigenic actions of central CARTp injection and extend these findings to water drinking. Gpr160ir was observed in both neuronal and nonneuronal cell types in regions known to be important in the multiple pharmacological effects of CARTp, identifying those areas as targets for future compromise of function studies.


Appetite Depressants/pharmacology , Brain Stem/drug effects , Drinking Behavior/drug effects , Drinking/drug effects , Eating/drug effects , Feeding Behavior/drug effects , Nerve Tissue Proteins/pharmacology , Receptors, G-Protein-Coupled/agonists , Animals , Brain Stem/metabolism , Glucagon-Like Peptide 1/metabolism , Glucagon-Like Peptide-1 Receptor/metabolism , Male , Neuroglia/drug effects , Neuroglia/metabolism , Neurons/drug effects , Neurons/metabolism , Rats, Sprague-Dawley , Receptors, G-Protein-Coupled/metabolism
9.
Int J Biol Macromol ; 165(Pt B): 2231-2243, 2020 Dec 15.
Article En | MEDLINE | ID: mdl-33058981

Konjac glucomannan (KGM) is a hypoglycemic polysaccharide with a wide range of molecular weights. But study on hypoglycemic effects of KGMs relate to molecular weight is limited. In this study, KGMs with high and medium molecular weights, and the degraded KGMs were analyzed with physicochemical properties, hypoglycemic effects and mechanisms. Results showed that as the molecular weight KGMs decreased, the viscosity decreased, molecular flexibility increased, while chemical groups, crystal structures and main chains showed little change. KGMs with medium molecular weights (KGM-M1, KGM-M2) showed better effects on increasing body weight, decreasing levels of fasting blood glucose, insulin resistance, total cholesterol and low density lipoprotein cholesterol, and enhancing integrity of pancreas and colon, than KGMs with high or low molecular weights (KGM-H, KGM-L) in type 2 diabetic rats. Mechanism analysis suggested that KGM-M1 and KGM-M2 had higher antioxidant and anti-inflammatory activities on elevating superoxide dismutase, decreasing malondialdehyde and tumor necrosis factor-α levels. Moreover, KGM-M1 and KGM-M2 increased gut microbiota diversity, Bacteroidetes/Firmicutes ratio and Muribaculaceae, decreased Romboutsia and Klebsiella, and improved 6 diabetic related metabolites. Combined, KGM-M1 and KGM-M2 showed higher hypoglycemic effects, due to regulatory activities of antioxidant, anti-inflammatory, intestinal microbiota, and relieved metabolic disorders.


Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/therapeutic use , Mannans/therapeutic use , Animals , Biomarkers/metabolism , Blood Glucose/metabolism , Body Weight/drug effects , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/pathology , Drinking Behavior/drug effects , Fasting/blood , Feces/microbiology , Feeding Behavior/drug effects , Gastrointestinal Microbiome/drug effects , Glucagon-Like Peptide 1/metabolism , Glucose Tolerance Test , Hypoglycemic Agents/pharmacology , Insulin Resistance , Lipids/blood , Magnetic Resonance Spectroscopy , Male , Mannans/pharmacology , Molecular Weight , Multivariate Analysis , Oxidative Stress/drug effects , Phylogeny , Rats, Sprague-Dawley , Scattering, Radiation , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared , X-Ray Diffraction
10.
PLoS One ; 15(9): e0239270, 2020.
Article En | MEDLINE | ID: mdl-32936829

In a between-subject comparison of two memantine administration schedules we observed that treatment with the NMDA receptor antagonist memantine before testing sessions reduced ingestion of a 10% sucrose solution in rats, due to reduced licking burst size, thus suggesting a blunted hedonic response. Conversely, daily post-session administration reduced burst number, indicating a reduced level of behavioural activation, likely due to the development of conditioned taste aversion (CTA). In this study, the effect of pre-session and post-session memantine administration was investigated within-subjects. Memantine was administered in daily intraperitoneal injections for 13 days, on alternate days, either 1-h before-"before testing" sessions-or immediately after a 30-min session-"after testing" sessions. The effects on the microstructure of licking for a 10% sucrose solution were examined in the course of treatment and for 21 days after treatment discontinuation. The results show reduced burst size in the "before testing" sessions, without effects on the intra-burst lick rate, an index of motoric effects. Moreover, burst number was reduced since the third session of both administration conditions until the end of treatment. Interestingly, the effect of memantine of reducing the activation of ingestive behaviour was less pronounced in this study with respect to that observed with the previous study post-session administration schedule, in spite of the longer treatment. This apparent paradox might be explained if one considers these effects as instances of a memory-related effect, such as the development of CTA. In the framework of this hypothesis, the "before testing" sessions, not being followed by memantine administration, can be considered as extinction sessions performed every other day. Moreover, the animals treated with memantine at the highest dose failed to recover to pre-treatment ingestion levels 21 days after treatment discontinuation, while the animals treated after testing sessions in the previously published study showed a complete recovery well before the 15th day test. Within the same interpretative framework, this might depend by the reduced number and frequency of the extinction trials-i.e. the number of the sessions run after treatment discontinuation-in the present study. These results provide further support to the conclusion that memantine administration before sessions reduce burst size, an effect which is likely due to blockade of NMDA receptors occurring during behavioural testing. The observation that this effect can be obtained even in absence of a reduced intra-burst lick rate, which rules out the involvement of motor impairment, provides an important piece of evidence in support to the interpretation of this effect as a blunted hedonic response. Moreover, these results provide further evidence that burst number reduction is due to a memory-related effect induced by memantine administration after sessions.


Feeding Behavior/drug effects , Memantine/pharmacology , Memory/drug effects , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Animals , Conditioning, Classical/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Drinking Behavior/drug effects , Eating , Humans , Memantine/adverse effects , Memory/physiology , Rats , Receptors, N-Methyl-D-Aspartate/genetics
11.
Food Chem Toxicol ; 144: 111625, 2020 Oct.
Article En | MEDLINE | ID: mdl-32738367

This study was designed to examine fetal and maternal toxicity of curcumin (CURC) loaded lipid-core nanocapsules (LNC) prepared with poly(ϵ-caprolactone) as a polymer, administered during the organogenesis period. Free CURC and CURC loaded-LNC (C-LNC) (2 mg/kg), blank LNC (B-LNC) and saline (CONTROL) were administered per oral route from the 7° to 13° gestational day (GD). Dams were evaluated daily for body weight gain, clinical signs, water and food intake. On 20° GD, dams were euthanized, organs were weighed and blood was collected for biochemical determinations. Fetal biometrics and external morphological anomalies were assessed. Also, were performed histopathological analysis of placenta and measurement of cytokines levels in placental and fetal liver tissues. All groups did not cause changes in dams during the pregnancy. Furthermore, treatments did not cause external morphological changes and delayed fetal development. Still, for histopathological analysis of placental tissue, treatments did not cause alterations in evaluated parameters. For cytokines levels, CURC and C-LNC caused a decrease in placental levels of TNF-α. Therefore, we have demonstrated that C-LNC did not cause toxicological effects (mother and fetus), in the same manner as pattern bioactive compound, proving to be a promising nutraceutical delivery system for maternal supplementation with CURC.


Curcumin/administration & dosage , Fetal Development/drug effects , Lipids/chemistry , Nanocapsules , Placenta/drug effects , Polyesters/administration & dosage , Animals , Body Weight/drug effects , Cytokines/metabolism , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Female , Male , Maternal-Fetal Exchange , Placenta/metabolism , Pregnancy , Rats, Wistar
12.
Food Chem Toxicol ; 144: 111612, 2020 Oct.
Article En | MEDLINE | ID: mdl-32738370

Propyl-propane-thiosulfonate (PTSO) is one of the main organosulfur compounds present in Allium essentials oil. Different applications in the food sector have been proposed for PTSO, such as food and feed additive and as active packaging. However, the authorization of its use depends on its toxicity profile. Thus, as a part of its safety assessment, in this work a repeated dose 90-day oral toxicity study has been conducted for the first time in rats following the OECD guideline 408. PTSO was administered to groups of 10 male and 10 female rats at dose levels of 0, 14, 28, and 55 mg/kg/day. No clinical signs or mortality and no changes in body weight, food consumption and feed conversion efficiency were detected through the study. Moreover, no treatment-related changes in hematological and biochemical parameters were observed, for either sex or dose groups. The histopathology study performed revealed no differences in organ weights, and no morphological and histopathological changes were observed. Based on these results, the no-observed-adverse-effect level (NOAEL) of PTSO was judged to be ≥ 55 mg/kg/day for both sexes.


Toxicity Tests, Subchronic , Administration, Oral , Animals , Body Weight/drug effects , Clinical Chemistry Tests , Dose-Response Relationship, Drug , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Female , Hematologic Tests , Male , No-Observed-Adverse-Effect Level , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Weight Gain/drug effects
13.
Sci Rep ; 10(1): 11974, 2020 07 20.
Article En | MEDLINE | ID: mdl-32686722

The use of non-nutritive sweeteners such as saccharin is widely prevalent. Although saccharin is considered safe for human consumption, it produces behavioral changes in experimental animals. We report that saccharin's behavioral effects are much more pervasive than currently recognized. In a mouse model, saccharin exposure produced motor impulsivity not only in the saccharin-exposed males but also in their offspring. In addition, the offspring showed locomotor hyperactivity and working memory deficit not observed in fathers. Spermatazoal DNA was hypermethylated in the saccharin-exposed fathers, especially at dopamine receptor promoter regions, suggesting that epigenetic modification of germ cell DNA may mediate transgenerational transmission of behavioral phenotypes. Dopamine's role in hyperactivity was further highlighted by the finding that the stimulant drug methylphenidate mitigated the hyperactivity. Nicotine is another substance that is widely used. Its use via smokeless tobacco products, some of which contain saccharin, is on the rise contributing to concerns about adverse outcomes of co-exposure to saccharin and nicotine. We found that co-exposure of male mice to saccharin and nicotine produced significant behavioral impairment in their offspring. Thus, our data point to potential adverse neurobehavioral consequences of exposure to saccharin alone or saccharin and nicotine for the exposed individuals and their descendants.


Behavior, Animal/drug effects , Nicotine/pharmacology , Saccharin/pharmacology , Animals , Body Weight/drug effects , Crosses, Genetic , DNA Methylation/drug effects , DNA Methylation/genetics , Drinking Behavior/drug effects , Female , Male , Methylphenidate/pharmacology , Mice, Inbred C57BL , Motor Activity/drug effects , Phenotype , Spermatozoa/drug effects , Spermatozoa/metabolism
14.
Behav Brain Res ; 383: 112537, 2020 04 06.
Article En | MEDLINE | ID: mdl-32032742

The anterior cingulate cortex (ACC), is known to be intimately involved in food-related motivational processes and their behavioral organization, primarily by evaluating hedonic properties of the relevant stimuli. In the present study, the involvement of cingulate cortical interleukin-1ß (IL-1ß) mediated mechanisms in a) gustation associated facial and somato-motor behavioral patterns of Wistar rats were examined in taste reactivity test (TR). In addition, b) conditioned taste aversion (CTA) paradigm was performed to investigate the role of these cytokine mechanisms in taste sensation associated learning processes, c) the general locomotor activity of the animals was observed in open field test (OPF), and d) the potentially negative reinforcing effect of IL-1ß was examined in conditioned place preference test (CPP). During the TR test, species specific behavioral patterns in response to the five basic tastes were analyzed. Response rates of ingestive and aversive patterns of the cytokine treated and the control groups differed significantly in case of the weaker bitter (QHCl, 0.03 mM), and the stronger umami (MSG, 0.5 M) tastes. IL-1ß itself did not elicit CTA, it did not interfere with the acquisition of LiCl induced CTA, and it also failed to cause place preference or aversion in the CPP test. In the OPF paradigm, however, significant differences were found between the cytokine treated and the control groups in the rearing and grooming, the number of crossings, and in the distance moved. Our results indicate the involvement of cingulate cortical IL-1ß mechanisms in the control of taste perception and other relevant behavioral processes.


Behavior, Animal/drug effects , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Gyrus Cinguli , Interleukin-1beta/pharmacology , Taste Perception/drug effects , Animals , Conditioning, Psychological , Drinking/drug effects , Eating/drug effects , Exploratory Behavior/drug effects , Locomotion/drug effects , Microinjections , Motivation , Rats
15.
Exp Brain Res ; 238(1): 73-80, 2020 Jan.
Article En | MEDLINE | ID: mdl-31784800

Experiments were done to investigate the role of glutamatergic systems in the median preoptic nucleus (MnPO) in the water ingestion induced by administration of angiotensin II (ANG II) in the subfornical organ (SFO) in the awake rat. Microdialysis methods were utilized to quantify the extracellular content of glutamate (Glu) in the region of MnPO. Microinjection of ANG II (10-10 M) into the SFO significantly increased the release of Glu in the MnPO in the rats under the condition that water is available for drinking and the rats under the condition that water is not available for drinking. The amount of initial maximal increases in the Glu levels elicited by the ANG II injection was quite similar in drinking and non-drinking rats, whereas the duration of the response was much longer in non-drinking than in drinking rats. The amount of water ingestion in 20 min immediately after the ANG II injection was significantly enhanced by previous injections of N-methyl-D-aspartate (NMDA, 10 µM) into the MnPO, while the ANG II-induced water ingestion was attenuated by pretreatment with the NMDA antagonist dizocilpine (MK-801, 10 µM). The amount of water intake elicited by the ANG II injection into the SFO was enhanced by previous injections of either the non-NMDA agonist kainic acid (KA, 50 µM) or quisqualic acid (QA, 50 µM) into the MnPO. On the contrary, the ANG II-induced drinking response was diminished by pretreatment with the non-NMDA antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM) in the MnPO. Each injection of NMDA, KA, and QA into the MnPO produced drinking behavior. These results imply that the glutamatergic neural pathways to the MnPO may transmit the information for eliciting drinking in response to ANG II acting at the SFO. Our data further provide evidence that the ANG II-induced dipsogenic response may be mediated through both NMDA and non-NMDA glutamatergic receptor mechanisms in the MnPO.


Angiotensin II/pharmacology , Drinking Behavior/drug effects , Drinking Water/metabolism , Glutamic Acid/metabolism , Preoptic Area/drug effects , Preoptic Area/metabolism , Subfornical Organ/drug effects , Vasoconstrictor Agents/pharmacology , Animals , Male , Rats , Rats, Wistar
16.
Biomed Res Int ; 2019: 8428304, 2019.
Article En | MEDLINE | ID: mdl-31886260

Ayurvedic and traditional medical practitioners of Sri Lanka use the decoction of the immature inflorescence of Cocos nucifera L. (IC) variety aurantiaca for the treatment of menorrhagia. The progestogenic effect of the ethyl acetate soluble proanthocyanidins (EASPA) of the IC in female rats at a dose of 3.5 mg/kg body weight has been reported. Acute and subacute toxicity studies of EASPA of the IC carried out using female Wistar rats according to Organization for Economic Co-operation and Development (OECD) guidelines 423 and 407, respectively, are reported herein. In the acute toxicity study, a single dose of EASPA (2000 mg/kg body weight) was orally administered to rats, which were monitored for 14 days. In the subacute toxicity study, rats were orally administered with EASPA daily for 28 days at doses of 1.75, 3.5, 7, and 14 mg/kg body weight. No rat in either the acute or subacute toxicity study exhibited mortality or clinical signs of toxicity. Further, these rats did not show any significant change in their mean body weight, food, and water intake, haematological and biochemical parameters as well as in the results of their histopathological examinations compared to those of control group rats. According to results of the acute toxicity, the LD50 of EASPA is estimated to be greater than 2000 mg/kg body weight. Considering the results of the subacute toxicity study, the oral administration of EASPA daily for 28 days was well tolerated up to the dose, 14 mg/kg by rats. These results will be useful in the development of a novel therapeutic agent from EASPA of the IC for the treatment of menorrhagia, which incapacitates a considerable proportion of women worldwide.


Acetates/chemistry , Cocos/chemistry , Inflorescence/chemistry , Proanthocyanidins/toxicity , Toxicity Tests, Acute , Animals , Body Weight/drug effects , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Female , Organ Size/drug effects , Proanthocyanidins/isolation & purification , Rats, Wistar
17.
Sci Rep ; 9(1): 16347, 2019 11 08.
Article En | MEDLINE | ID: mdl-31705012

Thirst has evolved for vertebrate terrestrial adaptation. We previously showed that buccal drying induced a series of drinking behaviours (migration to water-taking water into the mouth-swallowing) in the amphibious mudskipper goby, thereby discovering thirst in ray-finned fish. However, roles of dipsogenic/antidipsogenic hormones, which act on the thirst center in terrestrial tetrapods, have remained unclear in the mudskipper thirst. Here we examined the hormonal effects on the mudskipper drinking behaviours, particularly the antagonistic interaction between angiotensin II (AngII) and atrial natriuretic peptide (ANP) which is important for thirst regulation in mammalian 'forebrain'. Expectedly, intracerebroventricular injection of ANP in mudskippers reduced AngII-increased drinking rate. ANP also suppressed the neural activity at the 'hindbrain' region for the swallowing reflex, and the maintenance of buccopharyngeal water due to the swallowing inhibition may attenuate the motivation to move to water. Thus, the hormonal molecules involved in drinking regulation, as well as the influence of buccopharyngeal water, appear to be conserved in distantly related species to solve osmoregulatory problems, whereas hormonal control of thirst at the forebrain might have been acquired only in tetrapod lineage during evolution.


Angiotensin II/administration & dosage , Atrial Natriuretic Factor/administration & dosage , Biological Evolution , Drinking Behavior/physiology , Ecosystem , Thirst/physiology , Water-Electrolyte Balance/physiology , Animals , Drinking Behavior/drug effects , Prosencephalon/drug effects , Prosencephalon/physiology , Rhombencephalon/drug effects , Rhombencephalon/physiology , Skates, Fish , Thirst/drug effects , Vasoconstrictor Agents/administration & dosage , Water-Electrolyte Balance/drug effects
18.
Sci Rep ; 9(1): 15053, 2019 10 21.
Article En | MEDLINE | ID: mdl-31636311

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease largely caused by cigarette smoking (CS) and is characterized by lung inflammation and airflow limitation that is not fully reversible. Approximately 50% of people with COPD die of a cardiovascular comorbidity and current pharmacological strategies provide little benefit. Therefore, drugs that target the lung and the cardiovascular system concurrently may be an advantageous therapeutic strategy. The aim of this study was to see whether losartan, an angiotensin-II AT1a receptor antagonist widely used to treat hypertension associated with cardiovascular disease, protects against CS-induced lung inflammation in mice. Male BALB/c mice were exposed to CS for 8 weeks and treated with either losartan (30 mg/kg) or vehicle daily. Mice were euthanized and bronchoalveolar lavage fluid (BALF) inflammation, and whole lung cytokine, chemokine and protease mRNA expression assessed. CS caused significant increases in BALF total cells, macrophages, neutrophils and whole lung IL-6, TNF-α, CXCL-1, IL-17A and MMP12 mRNA expression compared to sham-exposed mice. However, losartan only reduced CS-induced increases in IL-6 mRNA expression. Angiotensin-II receptor expression was reduced in lung tissue from CS-exposed mice. In conclusion, losartan did not inhibit CS-induced BALF cellularity despite reducing whole lung IL-6 mRNA and Ang-II receptor expression.


Cigarette Smoking/adverse effects , Losartan/pharmacology , Pneumonia/etiology , Animals , Bronchoalveolar Lavage Fluid , Chemokines/genetics , Chemokines/metabolism , Drinking Behavior/drug effects , Feeding Behavior/drug effects , Gene Expression Regulation/drug effects , Inflammation Mediators/metabolism , Lung/drug effects , Lung/pathology , Male , Mice, Inbred BALB C , Organ Size/drug effects , Pneumonia/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism
19.
Psychopharmacology (Berl) ; 236(12): 3497-3512, 2019 Dec.
Article En | MEDLINE | ID: mdl-31273401

RATIONALE: Analysis of lick pattern for sucrose and NaCl and of the forced swimming response after dopamine antagonist administration led us to suggest that dopamine on D1-like receptors is involved in behavioural activation, and the level of activation is "reboosted" on the basis of an evaluation process involving D2-like receptors. Although some studies investigated licking microstructure for water after dopamine antagonists, the within-session time course of their effect was never investigated. OBJECTIVES: The aims of this study were to further investigate the role of dopamine receptors in the mechanisms governing water ingestion, focussing on the within-session time course of the microstructure parameters, and to test the proposed hypothesis. MATERIALS AND METHODS: The effects of the dopamine D1-like receptor antagonist SCH 23390 (0.01-0.04 mg/kg) and of the dopamine D2-like receptor antagonist raclopride (0.025-0.25 mg/kg) on licking microstructure for water were examined in 20-h water-deprived rats in 30-min sessions. RESULTS: As previously observed with sucrose and NaCl, SCH 23390 reduced licking by reducing burst number, suggesting reduced behavioural activation. Moreover, it resulted in an increased burst size. Raclopride reduced the size of licking bursts, while their number was either increased or decreased depending on the dose. CONCLUSION: The results support the suggestion that D1 receptors are involved in behavioural activation and D2 receptors are involved in a related evaluation process. Within the framework of the proposed hypothesis, the increased burst size after D1-like receptor blockade might be interpreted as a pro-hedonic effect consequent to the increased cost of the activation of the licking response.


Drinking Behavior/physiology , Receptors, Dopamine D1/physiology , Receptors, Dopamine D2/physiology , Water Deprivation/physiology , Water/administration & dosage , Animals , Benzazepines/pharmacology , Dopamine Antagonists/pharmacology , Dopamine D2 Receptor Antagonists/pharmacology , Drinking Behavior/drug effects , Eating/drug effects , Eating/physiology , Eating/psychology , Male , Raclopride/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Dopamine D1/antagonists & inhibitors
20.
Brain Res ; 1718: 137-147, 2019 09 01.
Article En | MEDLINE | ID: mdl-31085158

It is known that angiotensin II (AII) is sensed by subfornical organ (SFO) to induce drinking behaviors and autonomic changes. AII at picomolar concentrations have been shown to induce Ca2+ oscillations and increase in the amplitude and frequency of spontaneous Ca2+ oscillations in SFO neurons. The present study was conducted to examine effects of nanomolar concentrations of AII using the Fura-2 Ca2+-imaging technique in acutely dissociated SFO neurons. AII at nanomolar concentrations induced an initial [Ca2+]i peak followed by a persistent [Ca2+]i increase lasting for longer than 1 hour. By contrast, [Ca2+]i responses to 50 mM K+, maximally effective concentrations of glutamate, carbachol, and vasopressin, and AII given at picomolar concentrations returned to the basal level within 20 min. The AII-induced [Ca2+]i increase was blocked by the AT1 antagonist losartan. However, losartan had no effect when added during the persistent phase. The persistent phase was suppressed by extracellular Ca2+ removal, significantly inhibited by blockers of L and P/Q type Ca2+ channels , but unaffected by inhibition of Ca2+ store Ca2+ ATPase. The persistent phase was reversibly suppressed by GABA and inhibited by CaMK and PKC inhibitors. These results suggest that the persistent [Ca2+]i increase evoked by nanomolar concentrations of AII is initiated by AT1 receptor activation and maintained by Ca2+ entry mechanisms in part through L and P/Q type Ca2+ channels, and that CaMK and PKC are involved in this process. The persistent [Ca2+]i increase induced by AII at high pathophysiological levels may have a significant role in altering SFO neuronal functions.


Angiotensin II/pharmacology , Subfornical Organ/drug effects , Subfornical Organ/metabolism , Action Potentials/drug effects , Angiotensin II/metabolism , Animals , Calcium/metabolism , Calcium Channels/drug effects , Calcium Channels/metabolism , Cytosol/drug effects , Drinking Behavior/drug effects , Drinking Behavior/physiology , Male , Neurons/drug effects , Neurons/metabolism , Neurosecretory Systems , Rats , Rats, Wistar , Subfornical Organ/physiology
...